Drug Profile


Alternative Names: Fortovase; Invirase; RO 318959; RO 318959/003

Latest Information Update: 30 Oct 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antiretrovirals; Isoquinolines; Quinolines
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed HIV infections

Most Recent Events

  • 18 Jul 2016 Biomarkers information updated
  • 26 Oct 2007 Final results from a phase IIIb clinical trial (Gemini) added to the adverse events and Viral Infections pharmacodynamics and therapeutic trials sections
  • 15 Nov 2006 Interim 24-week results from a phase IIIb clinical trial (Gemini study) in treatment-naive patients with HIV infections have been added to the adverse events and Viral infections therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top